Michael Gelband’s Enact Holdings ACT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-50,178
Closed -$1.99M 1506
2025
Q4
$1.99M Buy
+50,178
New +$1.89M 0.02% 767
2025
Q3
Sell
-103,746
Closed -$3.85M 1475
2025
Q2
$3.85M Buy
103,746
+10,298
+11% +$366K 0.03% 500
2025
Q1
$3.25M Buy
+93,448
New +$3.12M 0.03% 540
2024
Q4
Sell
-84,504
Closed -$3.07M 1452
2024
Q3
$3.07M Sell
84,504
-23,535
-22% -$803K 0.02% 578
2024
Q2
$3.31M Buy
108,039
+36,498
+51% +$1.11M 0.02% 586
2024
Q1
$2.23M Buy
71,541
+24,356
+52% +$691K 0.02% 657
2023
Q4
$1.36M Buy
47,185
+38,301
+431% +$1.07M 0.01% 698
2023
Q3
$242K Sell
8,884
-15,060
-63% -$418K ﹤0.01% 1471
2023
Q2
$602K Buy
+23,944
New +$584K ﹤0.01% 1288
2022
Q2
Sell
-19,150
Closed -$426K 1886
2022
Q1
$426K Sell
19,150
-11,839
-38% -$256K 0.01% 1623
2021
Q4
$641K Buy
+30,989
New +$670K 0.01% 1271

Other funds holding ACT

Michael Gelband's ACT Position: Q1 2026 in Review

Michael Gelband sold out of Enact Holdings (ACT) in Q1 2026, closing a stake of 50,178 shares — an estimated $1.99M sold.

Michael Gelband first reported a position in ACT in Q4 2021 and held it in 11 quarters. The position peaked at $3.85M in Q2 2025. 252 funds tracked by Wall St. Rank hold ACT as of Q1 2026.

  • Michael Gelband reported no remaining Enact Holdings position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 50,178 Enact Holdings shares in Q1 2026, an estimated $1.99M.
  • Michael Gelband first reported a position in Enact Holdings in Q4 2021 and held it in 11 quarters.
  • Michael Gelband's Enact Holdings position peaked at $3.85M in Q2 2025.
  • 252 funds tracked by Wall St. Rank held Enact Holdings as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.